ROSSI, Francesco
ROSSI, Francesco
Dipartimento di Medicina Sperimentale
Benefits of sacubitril/valsartan alone and in combination with dapagliflozin in a preclinical female model of cardiometabolic and age-related cardiac dysfunction
2026 Mele, Elena; Riemma, Maria Antonietta; Donniacuo, Maria; Telesca, Marialucia; Sorrentino, Grazia; D'Amario, Domenico; Scialò, Filippo; Cianflone, Eleonora; Cappetta, Donato; Torella, Daniele; Castaldo, Giuseppe; Rossi, Francesco; Berrino, Liberato; Urbanek, Konrad; De Angelis, Antonella
Intervention studies and antimicrobial resistance in Italy: An overview of the latest evidence
2026 Vitiello, A.; Zovi, A.; Sabbatucci, M.; Fabbro, E.; Ricciardi, W.; Villani, L.; Rezza, G.; Boccellino, M.; Capuano, A.; Rossi, F.; Gelormini, M.; Wong, D. L. F.; Blasi, F.; Bellan, C.; Acampa, M.; Bassetti, M.
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System
2025 Balzano, N.; Mascolo, A.; Ruggiero, D.; Rafaniello, C.; Paolisso, G.; Rossi, F.; Capuano, A.
Bite Damage to the Rigid Bronchoscope
2024 Cesaro, Cristiano; Caterino, Umberto; Rossi, Francesco; Masi, Umberto; Perrotta, Fabio; Zamparelli, Enzo; Cesaro, Flavio; Fiorelli, Alfonso
Effects of sacubitril-valsartan on aging-related cardiac dysfunction
2024 Telesca, Marialucia; De Angelis, Antonella; Donniacuo, Maria; Bellocchio, Gabriella; Riemma, Maria Antonietta; Mele, Elena; Canonico, Francesco; Cianflone, Eleonora; Torella, Daniele; D'Amario, Domenico; Patti, Giuseppe; Liantonio, Antonella; Imbrici, Paola; De Luca, Annamaria; Castaldo, Giuseppe; Rossi, Francesco; Cappetta, Donato; Urbanek, Konrad; Berrino, Liberato
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
2024 Riemma, Maria Antonietta; Mele, Elena; Donniacuo, Maria; Telesca, Marialucia; Bellocchio, Gabriella; Castaldo, Giuseppe; Rossi, Francesco; De Angelis, Antonella; Cappetta, Donato; Urbanek, Konrad; Berrino, Liberato
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database
2024 Ruggiero, R.; Mascolo, A.; Spezzaferri, A.; Carpentieri, C.; Torella, D.; Sportiello, L.; Rossi, F.; Paolisso, G.; Capuano, A.
Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch
2024 Telesca, M.; Donniacuo, M.; Bellocchio, G.; Riemma, M. A.; Mele, E.; Dell'Aversana, C.; Sgueglia, G.; Cianflone, E.; Cappetta, D.; Torella, D.; Altucci, L.; Castaldo, G.; Rossi, F.; Berrino, L.; Urbanek, K.; De Angelis, A.
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System
2024 Ruggiero, R.; Balzano, N.; Nicoletti, M. M.; di Mauro, G.; Fraenza, F.; Campitiello, M. R.; Rossi, F.; Capuano, A.
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database
2024 Mascolo, A.; Zinzi, A.; Gaio, M.; Ruggiero, D.; Scavone, C.; Rossi, F.; Capuano, A.
Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors
2023 Donniacuo, M; DE ANGELIS, Antonella; Telesca, M; Bellocchio, G; Riemma, M; Paolisso, P; Scisciola, L; Cianflone, E; Torella, D; Castaldo, G; Capuano, Annalisa; Urbanek, K; Berrino, L; Rossi, F; Cappetta, D
COVID-19 and atrial fibrillation: Intercepting lines
2023 Donniacuo, Maria; De Angelis, Antonella; Rafaniello, Concetta; Cianflone, Eleonora; Paolisso, Pasquale; Torella, Daniele; Sibilio, Gerolamo; Paolisso, Giuseppe; Castaldo, Giuseppe; Urbanek, Konrad; Rossi, Francesco; Berrino, Liberato; Cappetta, Donato
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
2023 Ruggiero, R.; Donniacuo, M.; Mascolo, A.; Gaio, M.; Cappetta, D.; Rafaniello, C.; Docimo, G.; Riccardi, C.; Izzo, I.; Ruggiero, D.; Paolisso, G.; Rossi, F.; De Angelis, A.; Capuano, A.
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome
2023 Urbanek, Konrad; Cappetta, Donato; Bellocchio, Gabriella; Antonietta Coppola, Maria; Imbrici, Paola; Telesca, Marialucia; Donniacuo, Maria; Riemma, MARIA ANTONIETTA; Mele, Elena; Cianflone, Eleonora; Naviglio, Silvio; Conte, Elena; Maria Camerino, Giulia; Mele, Marco; Bucci, Mariarosaria; Castaldo, Giuseppe; De Luca, Annamaria; Rossi, Francesco; Berrino, Liberato; Liantonio, Antonella; DE ANGELIS, Antonella
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?
2023 Mascolo, Annamaria; Sportiello, Liberata; Rafaniello, Concetta; Donniacuo, Maria; Ruggiero, Donatella; Scisciola, Lucia; Barbieri, Michelangela; Rossi, Francesco; Paolisso, Giuseppe; Capuano, Annalisa
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years
2023 Ruggiero, R.; Balzano, N.; Di Napoli, R.; Fraenza, F.; Pentella, C.; Riccardi, C.; Donniacuo, M.; Tesorone, M.; Danesi, R.; Del Re, M.; Rossi, F.; Capuano, A.
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management
2023 Ruggiero, R.; Di Napoli, R.; Balzano, N.; Ruggiero, D.; Riccardi, C.; Anatriello, A.; Cantone, A.; Sportiello, L.; Rossi, F.; Capuano, A.
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data
2023 Zinzi, A.; Gaio, M.; Liguori, V.; Cagnotta, C.; Paolino, D.; Paolisso, G.; Castaldo, G.; Nicoletti, G. F.; Rossi, F.; Capuano, A.; Rafaniello, C.
Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
2023 Zinzi, A.; Gaio, M.; Liguori, V.; Ruggiero, R.; Tesorone, M.; Rossi, F.; Rafaniello, C.; Capuano, A.
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
2023 Mascolo, A.; Rafaniello, C.; di Mauro, G.; Ruggiero, D.; Campitiello, M. R.; Donniacuo, M.; Berrino, P. M.; Rossi, F.; Paolisso, G.; Capuano, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Benefits of sacubitril/valsartan alone and in combination with dapagliflozin in a preclinical female model of cardiometabolic and age-related cardiac dysfunction | 1-gen-2026 | Mele, Elena; Riemma, Maria Antonietta; Donniacuo, Maria; Telesca, Marialucia; Sorrentino, Grazia; D'Amario, Domenico; Scialò, Filippo; Cianflone, Eleonora; Cappetta, Donato; Torella, Daniele; Castaldo, Giuseppe; Rossi, Francesco; Berrino, Liberato; Urbanek, Konrad; De Angelis, Antonella | |
| Intervention studies and antimicrobial resistance in Italy: An overview of the latest evidence | 1-gen-2026 | Vitiello, A.; Zovi, A.; Sabbatucci, M.; Fabbro, E.; Ricciardi, W.; Villani, L.; Rezza, G.; Boccellino, M.; Capuano, A.; Rossi, F.; Gelormini, M.; Wong, D. L. F.; Blasi, F.; Bellan, C.; Acampa, M.; Bassetti, M. | |
| Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System | 1-gen-2025 | Balzano, N.; Mascolo, A.; Ruggiero, D.; Rafaniello, C.; Paolisso, G.; Rossi, F.; Capuano, A. | |
| Bite Damage to the Rigid Bronchoscope | 1-gen-2024 | Cesaro, Cristiano; Caterino, Umberto; Rossi, Francesco; Masi, Umberto; Perrotta, Fabio; Zamparelli, Enzo; Cesaro, Flavio; Fiorelli, Alfonso | |
| Effects of sacubitril-valsartan on aging-related cardiac dysfunction | 1-gen-2024 | Telesca, Marialucia; De Angelis, Antonella; Donniacuo, Maria; Bellocchio, Gabriella; Riemma, Maria Antonietta; Mele, Elena; Canonico, Francesco; Cianflone, Eleonora; Torella, Daniele; D'Amario, Domenico; Patti, Giuseppe; Liantonio, Antonella; Imbrici, Paola; De Luca, Annamaria; Castaldo, Giuseppe; Rossi, Francesco; Cappetta, Donato; Urbanek, Konrad; Berrino, Liberato | |
| Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects | 1-gen-2024 | Riemma, Maria Antonietta; Mele, Elena; Donniacuo, Maria; Telesca, Marialucia; Bellocchio, Gabriella; Castaldo, Giuseppe; Rossi, Francesco; De Angelis, Antonella; Cappetta, Donato; Urbanek, Konrad; Berrino, Liberato | |
| Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database | 1-gen-2024 | Ruggiero, R.; Mascolo, A.; Spezzaferri, A.; Carpentieri, C.; Torella, D.; Sportiello, L.; Rossi, F.; Paolisso, G.; Capuano, A. | |
| Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch | 1-gen-2024 | Telesca, M.; Donniacuo, M.; Bellocchio, G.; Riemma, M. A.; Mele, E.; Dell'Aversana, C.; Sgueglia, G.; Cianflone, E.; Cappetta, D.; Torella, D.; Altucci, L.; Castaldo, G.; Rossi, F.; Berrino, L.; Urbanek, K.; De Angelis, A. | |
| Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System | 1-gen-2024 | Ruggiero, R.; Balzano, N.; Nicoletti, M. M.; di Mauro, G.; Fraenza, F.; Campitiello, M. R.; Rossi, F.; Capuano, A. | |
| Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database | 1-gen-2024 | Mascolo, A.; Zinzi, A.; Gaio, M.; Ruggiero, D.; Scavone, C.; Rossi, F.; Capuano, A. | |
| Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors | 1-gen-2023 | Donniacuo, M; DE ANGELIS, Antonella; Telesca, M; Bellocchio, G; Riemma, M; Paolisso, P; Scisciola, L; Cianflone, E; Torella, D; Castaldo, G; Capuano, Annalisa; Urbanek, K; Berrino, L; Rossi, F; Cappetta, D | |
| COVID-19 and atrial fibrillation: Intercepting lines | 1-gen-2023 | Donniacuo, Maria; De Angelis, Antonella; Rafaniello, Concetta; Cianflone, Eleonora; Paolisso, Pasquale; Torella, Daniele; Sibilio, Gerolamo; Paolisso, Giuseppe; Castaldo, Giuseppe; Urbanek, Konrad; Rossi, Francesco; Berrino, Liberato; Cappetta, Donato | |
| COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database | 1-gen-2023 | Ruggiero, R.; Donniacuo, M.; Mascolo, A.; Gaio, M.; Cappetta, D.; Rafaniello, C.; Docimo, G.; Riccardi, C.; Izzo, I.; Ruggiero, D.; Paolisso, G.; Rossi, F.; De Angelis, A.; Capuano, A. | |
| Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome | 1-gen-2023 | Urbanek, Konrad; Cappetta, Donato; Bellocchio, Gabriella; Antonietta Coppola, Maria; Imbrici, Paola; Telesca, Marialucia; Donniacuo, Maria; Riemma, MARIA ANTONIETTA; Mele, Elena; Cianflone, Eleonora; Naviglio, Silvio; Conte, Elena; Maria Camerino, Giulia; Mele, Marco; Bucci, Mariarosaria; Castaldo, Giuseppe; De Luca, Annamaria; Rossi, Francesco; Berrino, Liberato; Liantonio, Antonella; DE ANGELIS, Antonella | |
| Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? | 1-gen-2023 | Mascolo, Annamaria; Sportiello, Liberata; Rafaniello, Concetta; Donniacuo, Maria; Ruggiero, Donatella; Scisciola, Lucia; Barbieri, Michelangela; Rossi, Francesco; Paolisso, Giuseppe; Capuano, Annalisa | |
| Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years | 1-gen-2023 | Ruggiero, R.; Balzano, N.; Di Napoli, R.; Fraenza, F.; Pentella, C.; Riccardi, C.; Donniacuo, M.; Tesorone, M.; Danesi, R.; Del Re, M.; Rossi, F.; Capuano, A. | |
| Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management | 1-gen-2023 | Ruggiero, R.; Di Napoli, R.; Balzano, N.; Ruggiero, D.; Riccardi, C.; Anatriello, A.; Cantone, A.; Sportiello, L.; Rossi, F.; Capuano, A. | |
| Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data | 1-gen-2023 | Zinzi, A.; Gaio, M.; Liguori, V.; Cagnotta, C.; Paolino, D.; Paolisso, G.; Castaldo, G.; Nicoletti, G. F.; Rossi, F.; Capuano, A.; Rafaniello, C. | |
| Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study | 1-gen-2023 | Zinzi, A.; Gaio, M.; Liguori, V.; Ruggiero, R.; Tesorone, M.; Rossi, F.; Rafaniello, C.; Capuano, A. | |
| Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis | 1-gen-2023 | Mascolo, A.; Rafaniello, C.; di Mauro, G.; Ruggiero, D.; Campitiello, M. R.; Donniacuo, M.; Berrino, P. M.; Rossi, F.; Paolisso, G.; Capuano, A. |